Trials / Completed
CompletedNCT01526122
Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration
A PhaseⅠ Study to Compare the Pharmacokinetic Characteristics and Safety After Oral Administration of G0041(75/100mg) With Those of Clopidogrel 75mg & Aspirin 100mg Coadministration in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare characteristics and safety after oral administration of G0041(75/100mg) 2 tablets with those of Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules coadministration in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | G0041(75/100mg) | G0041(75/100mg) 2 capsules(Clopidogrel 75mg \& Aspirin 100mg in 1 capsule), PO |
| DRUG | Clopidogrel & Aspirin | Clopidogrel 75mg 2 tablets \& Aspirin 100mg 2 capsules, PO |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-02-03
- Last updated
- 2014-10-01
Source: ClinicalTrials.gov record NCT01526122. Inclusion in this directory is not an endorsement.